Market

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

  • NSE CodeGLAXOEQ
  • BSE Code500660
  • ISININE159A01016
  • IndustryPharmaceuticals


Company Information

Management

Mr. Ajay Nadkarni

Co. Secretary & Compl. Officer

Mr. Ronojit Biswas

Chief Financial Officer

Mr. Aparajita Rajput

Vice President

Mr. Omkar Parnandiwar

Vice President

Incorporation Year

13/11/1924

Registered Address


Mumbai, Maharashtra - 400030
Tel: 022-24959595
Fax: 022-24959494

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

in.investorquery@gsk.com

Website

http://www.gsk-india.com

Listing

BSE, MCXSX, NSE

Corporate News

GlaxoSmith. Pharma. - Analysts/Institutional Investor...

21-Jul-2026|12:13PM

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Sch

GlaxoSmith. Pharma. - Board Meeting Intimation for Ap...

21-Jul-2026|11:59AM

Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the

GlaxoSmith. Pharma. has submitted to BSE the Sharehol...

10-Jul-2026|6:10PM

As of June 2026, 75.00% is owned by Foreign Promoters and 25.00% by Public.

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug75.95215.35
Aarti Drug410.953,750.74
Aarti Pharma684.356,205.67
Abbott India27,800.0059,073.06
Accent Micro504.251,209.65

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
SBI Midcap Fu..294.041.22
Kotak Large &..269.530.86
Nippon India ..223.772.47
Nippon India ..136.970.28
SBI Dividend ..110.261.30

Board Meetings

DatePurpose
03/08/2026Quarterly Results
13/05/2026Audited Results & D..
09/02/2026Quarterly Results
06/11/2025Quarterly Results
01/08/2025Quarterly Results
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.